Stan Miele

Advisory Board Member

Stan Miele is a senior life-science executive whose commercial, operational, and strategic leadership brings significant value to EvE’s advisory platform. With more than 30 years of experience across pharmaceuticals, medical devices, and biotech, Stan has played a central role in scaling companies, executing global partnerships, and guiding products from development to commercialization – expertise directly relevant to investors, strategic acquirers, and early-stage innovators.

Stan’s background includes leading P&L operations, building commercial infrastructures, negotiating global alliances, and overseeing multiple drug and device launches across the U.S., Europe, and specialty markets. His deep understanding of market access, competitive landscapes, and commercialization pathways enables sharper commercial due-diligence insights and informed strategic decision-making for growth-stage companies.

He has served in senior executive roles including: President, Chief Commercial Officer, and head of U.S. subsidiaries – where he drove sustained revenue acceleration, executed restructuring initiatives, and represented companies in investor conferences, earnings discussions, and board meetings.

Stan also brings a distinguished 14-year record in the U.S. Army Medical Service Corps (active and reserve), including five years in Germany in various leadership roles, culminating in the rank of Major. His disciplined, results-driven leadership style now serves companies navigating capital raises, partnerships, and strategic transitions.

Relevant Expertise for EvE Clients:

Commercial Strategy · P&L Leadership · Global Alliances · Market Access & Launch Planning · Clinical & Regulatory Positioning · Manufacturing Strategy · Licensing & BD · Capital Raising Support · Commercial Due Diligence.

Our Exceptional Team

GUY TAUBIN

CEO

SHMUEL MIZRACHI GINAT

CBO

RONEN BERGER

CRO

Our Exceptional Team

GUY TAUBIN

CEO

SHMUEL MIZRACHI GINAT

CBO

RONEN BERGER

CRO

Stay connected for exclusive news, strategy updates, industry insights, and more.

Contact Us

*I consent to receiving promotional content from the company

Call Now Button Skip to content